In vitro stability of a novel compliant poly(carbonate-urea)urethane to oxidative and hydrolytic stress.
暂无分享,去创建一个
Alexander M Seifalian | A. Seifalian | R. J. Carson | G. Hamilton | H. Salacinski | Henryk J Salacinski | Alan Edwards | George Hamilton | A. Edwards | Nigel R Tai | Robert J Carson | N. Tai
[1] R. Guidoin,et al. A new generation of polyurethane vascular prostheses: rara avis or ignis fatuus? , 1999, Journal of biomedical materials research.
[2] T. N. Salthouse. Cellular enzyme activity at the polymer-tissue interface: a review. , 1976, Journal of biomedical materials research.
[3] James M. Anderson,et al. Polyurethane Elastomer Biostability , 1995, Journal of biomaterials applications.
[4] J M Anderson,et al. Human plasma alpha 2-macroglobulin promotes in vitro oxidative stress cracking of Pellethane 2363-80A: in vivo and in vitro correlations. , 1993, Journal of biomedical materials research.
[5] M. Szycher,et al. Surface Fissuring of Polyurethanes Following In Vivo Exposure , 1985 .
[6] J. Santerre,et al. Synthesis of Cholesterol Esterase by Monocyte-Derived Macrophages: A Potential Role in the Biodegradation of Poly(Urethane)s , 1999, Journal of biomaterials applications.
[7] P. Urbański,et al. Glass wool-H2O2/CoCl2 test system for in vitro evaluation of biodegradative stress cracking in polyurethane elastomers. , 1995, Journal of biomedical materials research.
[8] A. M. Reed,et al. A Solution Grade Biostable Polyurethane Elastomer: ChronoFlex® AR , 1994, Journal of biomaterials applications.
[9] A. Brandwood,et al. Degradation of medical-grade polyurethane elastomers: the effect of hydrogen peroxide in vitro. , 1993, Journal of biomedical materials research.
[10] A. Hiltner,et al. Long term biodegradation in vitro of poly(ether urethane urea): a mechanical property study , 1987 .
[11] S. Froelich,et al. Cholesterol esterase catalyzed hydrolysis of mixed micellar thiophosphatidylcholines: a possible charge-relay mechanism. , 1991, Biochemistry.
[12] J M Anderson,et al. Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking. , 1991, Journal of biomedical materials research.
[13] H. Kehlet,et al. Postoperative ileus: a preventable event , 2000, The British journal of surgery.
[14] C. Nathan,et al. Secretory products of macrophages. , 1987, The Journal of clinical investigation.
[15] J. Santerre,et al. Application of macromolecular additives to reduce the hydrolytic degradation of polyurethanes by lysosomal enzymes. , 1997, Biomaterials.
[16] R. Guidoin,et al. Chemical stability of polyether urethanes versus polycarbonate urethanes. , 1997, Journal of biomedical materials research.
[17] A. Seifalian,et al. Effect of prolonged pulsatile shear stress in vitro on endothelial cell seeded PTFE and compliant polyurethane vascular grafts. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[18] S. Bowald,et al. In Vitro and in Vivo Biodurability of a Compliant Microporous Vascular Graft , 1998, Journal of biomaterials applications.
[19] R. Landel,et al. Mechanical Properties of Polymers and Composites , 1993 .
[20] A. Hiltner,et al. Biodegradation of a polyurethane in vitro. , 1987, Journal of biomedical materials research.
[21] B. Ratner,et al. Variations between Biomer lots. 2: The effect of differences between lots on in vitro enzymatic and oxidative degradation of a commercial polyurethane. , 1993, Journal of biomedical materials research.
[22] J M Anderson,et al. In vivo biocompatibility and biostability of modified polyurethanes. , 1997, Journal of biomedical materials research.
[23] R Guidoin,et al. Physicochemical characterization of a hydrophilic microporous polyurethane vascular graft. , 1987, Journal of biomedical materials research.
[24] J. Santerre,et al. Biodegradation evaluation of polyether and polyester-urethanes with oxidative and hydrolytic enzymes. , 1994, Journal of biomedical materials research.
[25] J. Santerre,et al. Enzyme-biomaterial interactions: effect of biosystems on degradation of polyurethanes. , 1993, Journal of biomedical materials research.
[26] H. Griesser. Degradation of polyurethanes in biomedical applications—A review , 1991 .
[27] L Pinchuk,et al. A review of the biostability and carcinogenicity of polyurethanes in medicine and the new generation of 'biostable' polyurethanes. , 1994, Journal of biomaterials science. Polymer edition.
[28] K. Ting,et al. Functional consequences of phospholipase A2 activation in human monocytes. , 1990, Advances in experimental medicine and biology.
[29] A. Seifalian,et al. Compliance properties of conduits used in vascular reconstruction , 2000, The British journal of surgery.
[30] J. Santerre,et al. The effect of phospholipids on the biodegradation of polyurethanes by lysosomal enzymes. , 1997, Journal of biomaterials science. Polymer edition.
[31] A. Takahara,et al. Effect of soft segment chemistry on the biostability of segmented polyurethanes. II. In vitro hydrolytic degradation and lipid sorption. , 1992, Journal of biomedical materials research.
[32] I. Hinberg,et al. In vitro degradation of a poly(ether urethane) by trypsin. , 1991, Journal of biomedical materials research.
[33] D. Williams,et al. The biodegradation of poly(ether urethanes). , 1987, Journal of biomedical materials research.
[34] W. Quist,et al. Development of a Microporous Compliant Small Bore Vascular Graft , 1995, Journal of biomaterials applications.
[35] B. Ratner,et al. Analysis of in vitro enzymatic and oxidative degradation of polyurethanes. , 1988, Journal of biomedical materials research.